Items Tagged ‘B’

January 12th, 2016

brentuximab vedotin

By

Class: Biological Therapy and Chemotherapy Generic Name: brentuximab vedotin Trade Name: Adcetris® How is this drug used? Adcetris is used for the treatment of Hodgkin lymphoma that has progressed after autologous stem cell transplant or has progressed after at least two prior multi-agent chemotherapy regimens in patients who are not candidates for a stem cell […]

View full entry

Tags: B, Biological Therapy, Chemotherapy, Drug Dictionary


December 21st, 2015

Benlysta®

By

Class: Immunotherapy Generic Name: Belimumab Trade Name: Benlysta® For which conditions is this drug approved? Benlysta is approved to treat adults with active systemic lupus erythematosus (SLE or lupus) who are receiving other lupus medicines. What is the mechanism of action? Benlysta belongs to a group of drugs called monoclonal antibodies, which target, bind to, […]

View full entry

Tags: B, Drug Dictionary, Other


December 21st, 2015

Belimumab

By

Class: Immunotherapy Generic Name: Belimumab Trade Name: Benlysta® For which conditions is this drug approved? Benlysta is approved to treat adults with active systemic lupus erythematosus (SLE or lupus) who are receiving other lupus medicines. What is the mechanism of action? Benlysta belongs to a group of drugs called monoclonal antibodies, which target, bind to, […]

View full entry

Tags: B, Drug Dictionary, Other


May 19th, 2015

Blincyto®

By

Class: Biological Therapy Generic Name: Blinatumomab Trade Name: Blincyto® For which conditions is this drug approved? Blincyto is approved for treatment of a certain type of acute lymphoblastic leukemia (ALL): Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute ALL. What is the mechanism of action? Blincyto is a type of drug known as a monoclonal […]

View full entry

Tags: Acute Lymphoblastic Leukemia, B, Biological Therapy, blincyto, Drug Dictionary


May 19th, 2015

Blinatumomab

By

Class: Biological Therapy Generic Name: Blinatumomab Trade Name: Blincyto® For which conditions is this drug approved? Blincyto is approved for treatment of a certain type of acute lymphoblastic leukemia (ALL): Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute ALL. What is the mechanism of action? Blincyto is a type of drug known as a monoclonal […]

View full entry

Tags: Acute Lymphoblastic Leukemia, all, B, Biological Therapy, blincyto, Drug Dictionary


March 16th, 2015

Beleodaq®

By

Class: Biological Therapy Generic Name: belinostat Trade Name: Beleodaq® For which conditions is this drug approved? Beleodaq is approved for the treatment of peripheral T-cell lymphoma (PTCL) that comes back or does not respond to treatment. What is the mechanism of action? Beleodaq is an agent known as a histone deacetylase inhibitor. It works by […]

View full entry

Tags: B, Biological Therapy, Drug Dictionary, peripheral T-cell lymphoma


March 16th, 2015

belinostat

By

Class: Biological Therapy Generic Name: belinostat Trade Name: Beleodaq® For which conditions is this drug approved? Beleodaq is approved for the treatment of peripheral T-cell lymphoma (PTCL) that comes back or does not respond to treatment. What is the mechanism of action? Beleodaq is an agent known as a histone deacetylase inhibitor. It works by […]

View full entry

Tags: B, Biological Therapy, Drug Dictionary, peripheral T-cell lymphoma


October 22nd, 2012

Bosutinib

By

Class: Biological Therapy Generic Name: Bosutinib Trade Name: Bosulif® How is this drug used? Bosulif is used for the treatment ofPhiladelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults with resistance or intolerance to prior therapy. What is the mechanism of action? Bosulif is a kinase inhibitor. It limits cancer growth by interfering with certain […]

View full entry

Tags: B, Biological Therapy, Drug Dictionary


October 22nd, 2012

Bosulif®

By

Class: Biological Therapy Generic Name: Bosutinib Trade Name: Bosulif® How is this drug used? Bosulif is used for the treatment ofPhiladelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults with resistance or intolerance to prior therapy. What is the mechanism of action? Bosulif is a kinase inhibitor. It limits cancer growth by interfering with certain […]

View full entry

Tags: B, Biological Therapy, Drug Dictionary


October 22nd, 2012

Bosutinib

By

Class: Biological Therapy Generic Name: Bosutinib Trade Name: Bosulif® How is this drug used? Bosulif is used for the treatment ofPhiladelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults with resistance or intolerance to prior therapy. What is the mechanism of action? Bosulif is a kinase inhibitor. It limits cancer growth by interfering with certain […]

View full entry

Tags: B, Biological Therapy, Drug Dictionary


October 22nd, 2012

Bosulif®

By

Class: Biological Therapy Generic Name: Bosutinib Trade Name: Bosulif® How is this drug used? Bosulif is used for the treatment ofPhiladelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults with resistance or intolerance to prior therapy. What is the mechanism of action? Bosulif is a kinase inhibitor. It limits cancer growth by interfering with certain […]

View full entry

Tags: B, Biological Therapy, Drug Dictionary


October 14th, 2010

Bendamustine

By

Class: Chemotherapy Generic Name: Bendamustine (ben-duh-MU-steen) hydrochloride Trade Name: Treanda® For which conditions is this drug approved? Bendamustine is approved for treatment of chronic lymphocytic leukemia (CLL) and indolent (slow-growing) B-cell non-Hodgkin’s lymphoma (NHL) that has progressed during or within six months of treatment that includes the agent Rituxan® (rituximab). It is important for patients […]

View full entry

Tags: B, Chemotherapy


October 14th, 2010

Bendamustine

By

Class: Chemotherapy Generic Name: Bendamustine (ben-duh-MU-steen) hydrochloride Trade Name: Treanda® For which conditions is this drug approved? Bendamustine is approved for treatment of chronic lymphocytic leukemia (CLL) and indolent (slow-growing) B-cell non-Hodgkin’s lymphoma (NHL) that has progressed during or within six months of treatment that includes the agent Rituxan® (rituximab). It is important for patients […]

View full entry

Tags: B, Chemotherapy


December 29th, 2009

BCG

By

Class: Biologic therapy Generic Name: Bacillus Calmette-Guerin, BCG Trade Name: TheraCys®, TICE® For which conditions is this drug approved? BCG is FDA approved for the treatment of superficial bladder cancer. It is important for patients to remember that physicians have the ability to prescribe medication for conditions other than those for which the drug has […]

View full entry

Tags: B, Biological Therapy


April 28th, 2009

bicalutamide

By

Class: Hormonal therapy Generic Name: Bicalutamide (bye-keh-LOO-ta-mide) Trade Name: Casodex® For which conditions is this drug approved? Bicalutamide is FDA approved for the treatment of advanced prostate cancer (stage D2), in combination with a luteinizing hormone-releasing hormone (LHRH) analogue.  It is important for patients to remember that physicians have the ability to prescribe medication for […]

View full entry

Tags: B, Hormonal Therapy